SNNA - Sienna Biopharmaceuticals Inc.
Previous close
0.1358
0 0%
Share volume: 0
Last Updated: Mon 16 Dec 2019 06:00:00 AM CET
Pharmaceuticals: Major:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$0.14
0.00
0.00%
Summary score
34%
Profitability
25%
Dept financing
25%
Liquidity
38%
Performance
45%
Sector
Health Technology
Industry
Pharmaceuticals: Major
Long-term ratios 30-Sep-2015 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-36.27%
Return on assets
-12.45%
Return on sales
0%
Return on invested capital
-34.33%
Total debt ratio
57.11%
Debt ratio change over timeo
-2.59%
Current Ratio
5.42%
Quick Ratio
0%
Cash Position Ratio
4.68%
Short-term ratios 30-Sep-2018 - 30-Sep-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-42.44%
Return on assets
-12.73%
Return on sales
0%
Return on invested capital
-37.05%
Total debt ratio
67.03%
Debt ratio change over timeo
-2.69%
Current Ratio
5.6%
Quick Ratio
0%
Cash Position Ratio
3.96%
Last quarter ratios 30-Sep-2019
The data are presented for the financials results of the last quarter.
Return on equity
-17.19%
Return on assets
-20.33%
Return on sales
0%
Return on invested capital
-17.67%
Total debt ratio
46.88%
Debt ratio change over time
-3.05%
Current Ratio
15.27%
Quick Ratio
0%
Cash Position Ratio
8.94%
Performance ratios (change over 4 years) 30-Sep-2015 - 30-Sep-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-8.79%
Return on assets
-59.99%
Return on sales
0%
Return on invested capital
3.04%
Total debt ratio
-258.76%
Debt ratio change over time
-2.59%
Current Ratio
-21.23%
Quick Ratio
0%
Cash Position Ratio
-17.91%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | SNNA | FTSV | PRNB | RARX |
---|---|---|---|---|
Return on equity | -36.27% | -19.36% | -4.04% | -14.62% |
Return on assets | -12.45% | -16.77% | -0.89% | -13.27% |
Return on sales | 0% | 0% | 0% | 0% |
Return on invested capital | -34.33% | 161.81% | -701.97% | 759.23% |
Profitability | 25% | 5% | 50% | 25% |
Total debt ratio | 57.11% | 15.55% | 34.11% | 9.59% |
Debt ratio change over time | -2.59% | -0.91% | -0.98% | -1% |
Dept financing | 25% | 32% | 15% | 4% |
Current Ratio | 5.6% | 7.5% | 12.43% | 20.49% |
Quick Ratio | 0% | 0% | 0% | 0% |
Cash Position Ratio | 3.96% | 0.96% | 2.15% | 19.85% |
Liquididy | 41% | 14% | 19% | 50% |
Short-term ratios | SNNA | FTSV | PRNB | RARX |
---|---|---|---|---|
Return on equity | -42.44% | -17.06% | -4.04% | -9.72% |
Return on assets | -12.73% | -15.33% | -3.59% | -9.49% |
Return on sales | 0% | 0% | 0% | 0% |
Return on invested capital | -37.05% | 148.9% | -701.97% | 2781.08% |
Profitability | 25% | 1% | 50% | 25% |
Total debt ratio | 67.03% | 14.74% | 11.92% | 6.35% |
Debt ratio change over time | -2.69% | -0.91% | -0.98% | -0.99% |
Dept financing | 25% | 30% | 4% | 2% |
Current Ratio | 5.6% | 7.5% | 12.43% | 20.49% |
Quick Ratio | 0% | 0% | 0% | 0% |
Cash Position Ratio | 3.96% | 0.96% | 2.15% | 19.85% |
Liquididy | 37% | 10% | 18% | 50% |